Published in Transl Res on March 25, 2014
IKKβ in intestinal mesenchymal cells promotes initiation of colitis-associated cancer. J Exp Med (2015) 1.18
Human esophageal myofibroblasts secrete proinflammatory cytokines in response to acid and Toll-like receptor 4 ligands. Am J Physiol Gastrointest Liver Physiol (2015) 0.88
Graded effects of unregulated smooth muscle myosin on intestinal architecture, intestinal motility and vascular function in zebrafish. Dis Model Mech (2016) 0.76
Interleukin 6 inhibition by triptolide prevents inflammation in a mouse model of ulcerative colitis. Exp Ther Med (2017) 0.75
Mechanisms of intracellular protein transport. Nature (1994) 13.54
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol (2007) 9.37
Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am J Physiol (1999) 3.45
IL-1 beta -converting enzyme (caspase-1) in intestinal inflammation. Proc Natl Acad Sci U S A (2001) 3.21
Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis (2010) 3.11
Two physically, functionally, and developmentally distinct peritoneal macrophage subsets. Proc Natl Acad Sci U S A (2010) 2.94
Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol (2005) 2.80
Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci (1993) 2.62
Mouse models of inflammatory bowel disease. Adv Drug Deliv Rev (2007) 2.42
Role of cytokines in inflammatory bowel disease. World J Gastroenterol (2008) 2.30
Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen. Nat Med (1999) 2.17
IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells. J Exp Med (2012) 2.11
Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm Bowel Dis (2007) 1.94
The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment. Cancer Cell (2011) 1.92
Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. Gut (2002) 1.60
Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol (2012) 1.44
Animal models of inflammatory bowel disease. Prog Mol Biol Transl Sci (2012) 1.29
Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications. Gut (2006) 1.24
Epimorphin deletion protects mice from inflammation-induced colon carcinogenesis and alters stem cell niche myofibroblast secretion. J Clin Invest (2010) 1.22
Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages. Gastroenterology (2008) 1.18
A regenerative role for bone marrow following experimental colitis: contribution to neovasculogenesis and myofibroblasts. Gastroenterology (2005) 1.16
Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice. Int J Mol Med (2004) 1.13
Epimorphin(-/-) mice have increased intestinal growth, decreased susceptibility to dextran sodium sulfate colitis, and impaired spermatogenesis. J Clin Invest (2006) 1.11
Activation of epithelial STAT3 regulates intestinal homeostasis. Cell Cycle (2010) 1.10
Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases. World J Gastroenterol (2011) 1.05
Intestinal mesenchymal cells. Curr Gastroenterol Rep (2010) 1.05
Epimorphin expression in intestinal myofibroblasts induces epithelial morphogenesis. J Clin Invest (2002) 0.99
Lipoxin A(4) reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-kappaB activation. J Pharmacol Exp Ther (2009) 0.99
Interleukin-6 induces S100A9 expression in colonic epithelial cells through STAT3 activation in experimental ulcerative colitis. PLoS One (2012) 0.98
Human colonic myofibroblasts promote expansion of CD4+ CD25high Foxp3+ regulatory T cells. Gastroenterology (2011) 0.96
Triptolide ameliorates IL-10-deficient mice colitis by mechanisms involving suppression of IL-6/STAT3 signaling pathway and down-regulation of IL-17. Mol Immunol (2010) 0.94
The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases. Am J Physiol Gastrointest Liver Physiol (2013) 0.94
The specific type-4 phosphodiesterase inhibitor mesopram alleviates experimental colitis in mice. J Pharmacol Exp Ther (2003) 0.92
Deletion of intestinal epithelial cell STAT3 promotes T-lymphocyte STAT3 activation and chronic colitis following acute dextran sodium sulfate injury in mice. Inflamm Bowel Dis (2013) 0.92
Decreased MAPK- and PGE2-dependent IL-11 production in Gialpha2-/- colonic myofibroblasts. Am J Physiol Gastrointest Liver Physiol (2007) 0.87
Characterization of rat epimorphin/syntaxin 2 expression suggests a role in crypt-villus morphogenesis. Am J Physiol (1998) 0.87
Contribution of Fibroblast and Mast Cell (Afferent) and Tumor (Efferent) IL-6 Effects within the Tumor Microenvironment. Cancer Microenviron (2012) 0.86
Involvement of epimorphin in the repair of experimental renal fibrosis in mice. Lab Invest (2010) 0.85
Intestinal subepithelial myofibroblasts in inflammatory bowel diseases. J Gastroenterol (2002) 0.82
Epimorphin expression in human colonic myofibroblasts. Int J Mol Med (2004) 0.81
Altered expression of epimorphin in ulcerative colitis. J Gastroenterol Hepatol (2003) 0.80
Regulated exocytosis in immune function: are SNARE-proteins involved? Respir Med (2000) 0.78